{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:29:44Z","timestamp":1769164184176,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ghir.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T02:08:18Z","timestamp":1460340498000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-6562","authenticated-orcid":false,"given":"Sema Ciftci","family":"Dogansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem Soyluk","family":"Selcukbiricik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul Ekiz","family":"Bilir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Yarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2016.04.004_bb0005","first-page":"639","article-title":"Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects","volume":"17","author":"Ben-Jonathan","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2016.04.004_bb0010","doi-asserted-by":"crossref","first-page":"34561","DOI":"10.1074\/jbc.274.50.35461","article-title":"Functional characterization of the intermediate isoform of the human prolactin receptor","volume":"274","author":"Kline","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2016.04.004_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5728(93)90282-4","article-title":"Differential effects of prolactin upon activation and differentiation of human B lymphocytes","volume":"47","author":"Lahat","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ghir.2016.04.004_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2011.11.009","article-title":"Prolactin and autoimmunity","volume":"11","author":"Shelly","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ghir.2016.04.004_bb0025","first-page":"184","article-title":"Interrelationship between TSH and prolactin secretion in patients with prolactinoma and autoimmune thyroiditis","volume":"100","author":"Pelkonen","year":"1982","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2016.04.004_bb0030","first-page":"35","article-title":"Thyroid autoimmunity in hyperprolactinemic disorders","volume":"104","author":"Ferrari","year":"1983","journal-title":"Acta.Endocrinol."},{"key":"10.1016\/j.ghir.2016.04.004_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arcmed.2004.11.007","article-title":"Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies","volume":"36","author":"Kramer","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ghir.2016.04.004_bb0040","first-page":"147","article-title":"An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs","volume":"90","author":"Giusti","year":"1999","journal-title":"Recenti Prog. Med."},{"issue":"9","key":"10.1016\/j.ghir.2016.04.004_bb0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.euroneuro.2008.04.014","article-title":"Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia","volume":"18","author":"Poyraz","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.ghir.2016.04.004_bb0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1507\/endocrj1954.38.517","article-title":"Anti-thyroid antibodies in patients with hyperprolactinemia","volume":"38","author":"Ishibashi","year":"1991","journal-title":"Endocrinol. Jpn."},{"issue":"6","key":"10.1016\/j.ghir.2016.04.004_bb0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/cen.12217","article-title":"Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma","volume":"79","author":"Arslan","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2265.2002.01562.x","article-title":"Thyroid vascularity is increased in patients with active acromegaly","volume":"57","author":"Bogazzi","year":"2002","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2016.04.004_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF03343997","article-title":"Acromegaly study Group of the Italian Society of endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study","volume":"25","author":"Gasperi","year":"2002","journal-title":"J. Endocrinol. Investig."},{"issue":"5","key":"10.1016\/j.ghir.2016.04.004_bb0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2007-978620","article-title":"Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up","volume":"32","author":"Cannav\u00f2","year":"2000","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12020-013-9981-3","article-title":"Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients","volume":"45","author":"Dogan","year":"2014","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ghir.2016.04.004_bb0080","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s11102-015-0670-5","article-title":"Thyroid autoimmune disorders in patients with acromegaly","volume":"18","author":"Manavela","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2016.04.004_bb0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.04.004_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the pituitary society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"10.1016\/j.ghir.2016.04.004_bb0095","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Endocrine Society. Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.04.004_bb0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/thy.1999.9.1069","article-title":"Validation of ultrasonography of the thyroid gland for epidemiological purposes","volume":"11","author":"Knudsen","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ghir.2016.04.004_bb0105","series-title":"35th Annual Meeting of the European Thyroid Association Abstracts-P-81. Krakow, Poland, 10th\u201314th September","article-title":"TURDEP-II Study Group. Prevalence of Thyroid Disease in a Population-Based Survey in Turkey: TURDEP-II","author":"Satman","year":"2011"},{"issue":"10","key":"10.1016\/j.ghir.2016.04.004_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-2001-17904","article-title":"Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto's thyroiditis","volume":"33","author":"Legakis","year":"2001","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2016.04.004_bb0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5728(00)00302-7","article-title":"Prolactin in autoimmunity and antitumor defence","volume":"109","author":"Matera","year":"2000","journal-title":"J. Neuroimmunol."},{"issue":"21","key":"10.1016\/j.ghir.2016.04.004_bb0120","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/jnci\/djr373","article-title":"Thyroid dysfunction from antineoplastic agents","volume":"103","author":"Hamnvik","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ghir.2016.04.004_bb0125","first-page":"152","article-title":"Type 1T helper and type 2T helper cells: functions, regulation and role in protection and disease","volume":"21","author":"Romagnani","year":"1991","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.ghir.2016.04.004_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/0004-2730000002846","article-title":"Thyroid autoimmunity in patients with hyperprolactinemia: an observational study","volume":"58","author":"Onal","year":"2014","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ghir.2016.04.004_bb0145","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/endo-119-2-940","article-title":"Insulin like growth factor stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG","volume":"119","author":"Tramontano","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2016.04.004_bb0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12020-012-9864-z","article-title":"Expression and significance of IGF-1 and IGF-1R in thyroid nodules","volume":"44","author":"Liu","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2016.04.004_bb0155","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk","volume":"22","author":"Renehan","year":"2008","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.04.004_bb0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2265.1997.1680985.x","article-title":"The thyroid gland in acromegaly: an ultrasonographic study","volume":"46","author":"Cheung","year":"1997","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2016.04.004_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000329497","article-title":"Growth hormone is a modulator of lymphocyte migration","volume":"18","author":"Smaniotto","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.ghir.2016.04.004_bb0170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-3083.2002.01077.x","article-title":"The thymus gland: a target organ for the growth hormone","volume":"55","author":"Savino","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ghir.2016.04.004_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2012.06637.x","article-title":"Growth hormone modulates migration of thymocytes and peripheral T cells","volume":"1261","author":"Savino","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ghir.2016.04.004_bb0180","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"Am.J. Pathol."},{"key":"10.1016\/j.ghir.2016.04.004_bb0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0190","first-page":"23","article-title":"Prolactin, bromocriptine and autoimmune diseases","volume":"32","author":"Buskila","year":"1996","journal-title":"Isr. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.ghir.2016.04.004_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cellimm.2014.11.002","article-title":"Treating prolactinoma can prevent autoimmune diseases","volume":"294","author":"Watad","year":"2015","journal-title":"Cell. Immunol."},{"issue":"3","key":"10.1016\/j.ghir.2016.04.004_bb0200","first-page":"179","article-title":"Anti-inflammatory effects of bromocriptine in a patient with autoimmune polyglandular syndrome type 2","volume":"35","author":"Krysiak","year":"2014","journal-title":"Neuro. Endocrinol. Lett."},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2010.07.001","article-title":"Sex hormones and autoimmunity","volume":"133","author":"Gonz\u00e1lez","year":"2010","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.ghir.2016.04.004_bb0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/1744666X.4.2.221","article-title":"Hashimoto's thyroiditis: TGAb, TPOAb, TRAb and recovery from hypothyroidism","volume":"4","author":"Takasu","year":"2008","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ghir.2016.04.004_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.44.89","article-title":"Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis","volume":"44","author":"Notsu","year":"1997","journal-title":"Endocr. J."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637416300338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637416300338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:50:02Z","timestamp":1761087002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637416300338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":43,"alternative-id":["S1096637416300338"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2016.04.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}